---
id: 087
title: Intra-Abdominal Infections Empiric Therapy
category: clinical_syndromes
subcategory: intraabdominal
tags: [IAI, peritonitis, abscess, source-control, anaerobic-coverage]
difficulty: medium
---

## Question

What is empiric therapy for intra-abdominal infections? Use the **"Source Control + Gram-Neg + Anaerobes"** principle.

## Answer

### **Principles:**
1. **Source control** (drain abscess, repair perforation) = **MOST CRITICAL**
2. **Gram-negative** coverage (E. coli, Klebsiella)
3. **Anaerobic** coverage (Bacteroides fragilis)
4. **Enterococcus** coverage if high-risk (immunocompromised, post-op, healthcare-associated)

### **Empiric Regimens:**

**Community-Acquired, Mild-Moderate:**
- **Ceftriaxone + metronidazole** OR
- **Ciprofloxacin + metronidazole** OR
- **Ertapenem** 1g daily (single agent)

**Healthcare-Associated or Severe:**
- **Piperacillin-tazobactam** 3.375-4.5g IV q6h OR
- **Meropenem** 1g IV q8h (if risk of ESBL/resistant) OR
- **Cefepime + metronidazole**

**High Risk (add enterococcal coverage):**
- Above regimens + **ampicillin** 2g IV q4h OR
- Use pip-tazo or meropenem (both cover enterococci)

### **Duration:** 4-7 days (adequate source control) vs 7-14 days (inadequate source control)

## Key Points

### **Source Control:**
- **Most important** intervention
- Without source control â†’ antibiotics alone insufficient
- Examples: Drainage of abscess, appendectomy, cholecystectomy, bowel resection

### **Clinical Pearls:**
- **Source control** = #1 priority
- **Gram-negative + anaerobic** coverage mandatory
- **Enterococcal** coverage only if high-risk
- **Duration:** 4-7 days if adequate source control

## Sources

- [IDSA/SIS: Intra-Abdominal Infections Guidelines]

## Media

N/A
